Diaceutics PLC
Investor Overview
At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.
DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.
Investor Factsheet
Download our latest Investor Factsheet outlining key details about the DXRX business model and the opportunities for the platform to deliver a real difference in a high growth market.
Financial Calendar
2021
Year End
31st Dec2022
Half Year End
30th JunRelease of Final Results FY21
22nd MarGroup FY21 Results investor webinar
23rd MarFinancial Calendar
2021
Year End
31st Dec2022
Half Year End
30th JunRelease of Final Results FY21
22nd MarGroup FY21 Results investor webinar
23rd MarWhy invest in Diaceutics?
Diaceutics PLC Financial Year 2021 Results Presentation and Slide deck
March 2022Corporate Governance
Latest Investor News
Investor Alerts
If you would like to recieve investor email alerts, simply complete this form. If you have already subscribed, you can change your settings or unsubscribe here.